Fig. 1From: Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding propertiesThe Zero Residual silicone oil-free, 0.2-mL syringe (a) and Zero Residual Bubble Adapter (b). Note, the images are not to scaleBack to article page